GeneDx Holdings (WGSWW) Total Current Liabilities (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Total Current Liabilities data on file, last reported at $87.6 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $87.6 million, up 26.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $87.6 million (up 26.02% YoY), and the FY2025 annual result was $108.9 million, up 98.68% from the prior year.
• Total Current Liabilities fell to $87.6 million in Q1 2026 per WGSWW's latest filing, from $108.9 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $204.6 million in Q2 2022 and troughed at $50.7 million in Q1 2024.
• A 5-year average of $95.2 million and a median of $84.4 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 181.77% in 2022, then plunged 59.24% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $144.3 million in 2022, then sank by 59.24% to $58.8 million in 2023, then fell by 6.8% to $54.8 million in 2024, then surged by 98.68% to $108.9 million in 2025, then fell by 19.53% to $87.6 million in 2026.
• Business Quant data shows WGSWW's Total Current Liabilities at $87.6 million in Q1 2026, $108.9 million in Q4 2025, and $87.6 million in Q3 2025.